Global Periodontal Therapeutics Market to Grow by USD 105 Million during 2019-2023 |Technavio

ELMHURST, Ill. - Nov. 7, 2019 - PRLog -- Technavio's latest market research report on the global periodontal therapeutics market predicts the market to witness a CAGR of more than 6% during the forecast period. This research report segments the market by product (local antibiotics, and systemic antibiotics) and geography (North America, Europe, Asia, and ROW).

Advent of biologics

In the last few decades, the area of dental sciences has witnessed several advances in biologics. Indeed, the effectiveness of using biologics in periodontitis therapeutic area has evolved significantly over the years. For instance, Trafermin spray is a recombinant form of human basic fibroblast growth factor (rhb FGF) and is the first marketed rhb FGF available in Japan since June 2001. While the drug has been traditionally used for the treatment of pressure ulcers and other skin ulcers, its clinical importance for the treatment of periodontal diseases has been identified recently, and the drug has been re-acknowledged as a reliable drug. Hence, the advent of biologics is expected to drive the global periodontal therapeutics market growth during the forecast period.

Local antibiotics product segment will garner the highest share

The use of localized antibiotics for the treatment of periodontal diseases has increased significantly, mainly because these drugs offer targeted delivery, which increases the bioavailability of drug and provides improved pharmacologic effect. Localized drugs are also used in patients who respond inadequately to systemic antibiotics. Such advantages of using these localized antibiotics for the treatment of periodontal diseases will increase their demand during the forecast period.

Download the free sample report @ https://www.technavio.com/talk-to-us?report=IRTNTR31411&type=sample&src=report&utm_source=off-page&utm_medium=pr&utm_campaign=2019-ch-W27

Periodontal therapeutics to witness fastest adoption in North America

North America accounted for the highest market share in 2018 and is expected to remain the fastest growing region during the forecast period. This is mainly due to the increasing patient pool with periodontal diseases in the region, which increases the consumption of periodontal therapeutics. The patient pool in North America is dominated by the geriatric population, who are more susceptible to periodontal diseases. Hence, the growing geriatric population will have a significant impact on the periodontal therapeutics market growth during the forecast period.


Get the Complete Report @  https://www.technavio.com/report/global-periodontal-therapeutics-market-industry-analysis?utm_source=off-page&utm_medium=pr&utm_campaign=2019-ch-W27

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com